|
The
purpose of this call is to ensure, in particular, that the
authors of reports on clinical trials which might not have been
ready for reporting at the time of the fall abstract deadline,
have the opportunity to present at the annual spring meeting.
In the past, some large clinical trials have missed the
window of opportunity for presentation at our meeting, because
of circumstances beyond the control of the investigators, and
have subsequently been either reported in less prestigious or
less inclusive venues or published before the time of the next annual
meeting. Thus, the
need for a "late-breaking" session is clear.
In addition to large clinical trials, other important and
consequential pediatric research might also be considered.
All
abstracts will undergo peer review and scoring similar to other
abstracts, and the PAS Program Committee reserves the right to
decide whether the abstracts are appropriate for inclusion in a
Special Session. Our
process provides a predictable point of access for high-quality and news-breaking research that truly is late for
reasons beyond the control of investigators.
Importantly, this avenue is not an alternative to the
usual submission process or deadline in the fall.
If abstracts are not submitted sufficient in numbers or
not conducive to platform presentations, then some consideration
will be given to a poster session.
It is anticipated that the acceptance rate will be much
lower for all abstracts submitted during this late call and will depend primarily
on the scientific quality and the reason for the lateness.
In particular, evaluation for inclusion in the
late-breaking science session will be based on impact and
novelty. Emphasis
will be given to large clinical trials as well as breakthrough
reports of scientific consequence.
If
you need technical support or additional assistance, please
contact info@pas-meeting.org
(phone: 281-419-0052).
|
